3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
10
Myelodysplastic Syndromes
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia
6
Hodgkin Disease
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Graft vs Host Disease
4
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Blast Crisis
3
Anemia, Refractory, with Excess of Blasts
3
Waldenstrom Macroglobulinemia
2
Multiple Myeloma
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Prolymphocytic
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Congenital Abnormalities
2
Burkitt Lymphoma
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
beta-Thalassemia
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
trametinib
1
tazemetostat
1
palbociclib
1
olaparib
1
dabrafenib
1
Vemurafenib
1
Pharmacogenomic Variants
1
LY3023414
1
Genetic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytosis, Langerhans-Cell
×
Mycophenolic Acid
×
30 days
×
Clear all
No trials found.